Chemotherapy News and Research

Latest Chemotherapy News and Research

Personalized approach to treating side-effects of chemotherapy better for cancer patients

A new research study led by Dr. Mark Clemons, oncologist and associate cancer research scientist at The Ottawa Hospital, has shown that a personalized approach to treating one of the most expected side-effects of chemotherapy is far more effective than the existing "one size fits all" set of guidelines.

13 Nov 2015

Loyola and Notre Dame researchers report promising new approaches to treating cancer

Promising new approaches to treating cancer were reported during a recent meeting of researchers from Loyola University Chicago and the University of Notre Dame.

12 Nov 2015

New research examines previously unknown secret to DNA repair

Michael Hendzel knows all too well that there is little that people can do to control the stability of their genetic code. But he hopes his latest research will help impact this elusive and crucial aspect of medicine. Published in Nature Cell Biology, this research explores a previously unknown secret to DNA repair.

12 Nov 2015

MD Anderson study reveals why chemotherapy drugs not effective for many pancreatic cancer patients

A study at The University of Texas MD Anderson Cancer Center may explain why chemotherapy drugs such as gemcitabine are not effective for many pancreatic cancer patients, and perhaps point to new approaches to treatment including enhancing gemcitabine's ability to stop tumor growth.

12 Nov 2015

Surgical lung resection can improve outcomes in high-risk patients with early stage disease

Surgical lung resection, in which part of a lung is removed, can be a safe and effective treatment option for high-risk patients with early stage lung cancer, according to an article posted online by The Annals of Thoracic Surgery.

11 Nov 2015

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Boston Scientific has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based developer of endovascular and interventional cardiology technologies.

10 Nov 2015

Researchers find greater genetic diversity among cancer cells than anticipated

The most rigorous genetic sequencing ever carried out on a single tumor reveals far greater genetic diversity among cancer cells than anticipated. Researchers from the University of Chicago and the Beijing Institute of Genomics estimate that the tumor, about 3.5 centimeters in diameter, contained more than 100 million distinct mutations within the coding regions of its genes—thousands of times more than expected.

10 Nov 2015

Cancer survivors' journeys chronicled by Bethlehem artist and cancer survivor Susan Schaffer

Chronicling the journeys of cancer survivors, friends and family has been an emotional process, one filled with joy and shared sorrow for Bethlehem artist and cancer survivor Susan H. Schaffer. As part of her Visions of Hope series of acrylic paintings, Susan offers insight into the windows of the soul - her collection captures the eyes of the people willing to share their respective cancer journeys with her.

9 Nov 2015

Agios announces data from dose-escalation phase 1 study of AG-120 in patients with IDH1 mutant positive advanced solid tumors

Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.

9 Nov 2015

NTU Singapore scientists harness dead bacteria to destroy colon tumours cells effectively

Scientists from Nanyang Technological University have successfully used dead bacteria to kill colorectal cancer cells. Harvesting the Clostridium sporogenes bacteria found commonly in soil, the NTU team was able to harness the bacteria in its dead form, and its secretions, to destroy colon tumours cells effectively.

9 Nov 2015

Novel genetic therapy treats ‘incurable’ leukaemia

A new treatment that involves editing DNA has been used for the first time at Great Ormond Street Hospital to successfully treat drug-resistant leukaemia.

6 Nov 2015

Communication network makes astrocytomas more resistant to treatment

Astrocytomas are special type of brain tumours that are difficult to treat, because they do not respond to standard forms of treatment. One reason for this resistance could be their ability to form a communication network.

5 Nov 2015

Higher insulin levels linked to worse prognosis in advanced breast cancer

Patients with breast cancer that has spread to other parts of the body (metastasised) and who have higher insulin levels than normal, but are not diabetic, have a significantly worse prognosis compared with those with normal insulin levels, a researcher will tell the Advanced Breast Cancer Third International Consensus Conference tomorrow (Friday).

5 Nov 2015

Researchers team up to evaluate biological and genetic differences of GI cancers in race, ethnicity

Americans of African descent are at a significantly higher risk for developing and dying from Gastrointestinal (GI) cancers, which include colorectal and pancreatic cancers, compared to individuals who are of Caucasian descent.

5 Nov 2015

Drugs that target malignant cells increase life expectancy in advanced breast cancer patients

Clinical studies show that new drugs that target malignant cells of HER2-positive breast cancer, such as Pertuzumab and Trastuzumab Emtansine (T-DM1), increase life expectancy in patients with advanced breast cancer.

5 Nov 2015

CK5 protein marks ovarian cancer likely to be resistant to cisplatin

A University of Colorado Cancer Center study recently published in the International Journal of Gynecological Cancer shows that protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in breast cancer, also marks ovarian cancers likely to be resistant to the common chemotherapy cisplatin.

5 Nov 2015

CA 19-9 tumor marker test can help predict early-stage pancreatic cancer patients

Only 1 in 5 U.S. pancreatic cancer patients receive a widely available, inexpensive blood test at diagnosis that can help predict whether they are likely to have a better or worse outcome than average and guide treatment accordingly, a Mayo Clinic study shows.

4 Nov 2015

Study explores benefits of breast cancer adjuvant therapies

After breast cancer surgery, women are prescribed adjuvant (or follow-up) therapies such as chemotherapy and endocrine drugs to reduce the risk of the cancer returning. It's been assumed that the treatment effects of these therapies remain constant over time, but a new study from the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio suggests the opposite is true.

4 Nov 2015

New clinical trial uses aggressive treatment method for patients with pancreas cancer

Pancreas cancer remains one of the deadliest cancers worldwide. In the United States, it accounts for only three percent of all diagnosed cancers but it causes almost seven percent of all cancer deaths. A pancreas cancer diagnosis often comes after age 50 and after the cancer has spread, making it difficult to remove surgically.

4 Nov 2015

Chemotherapy treatment can contribute to long-term neurocognitive deficits in pediatric brain tumor survivors

More children are surviving malignant brain tumors than in the past, thanks to the use of intense treatments using platinum-based chemotherapy (cisplatin and high-dose carboplatin). Unfortunately, the therapy has a known side effect of permanent hearing loss, resulting from damage to the inner ear.

4 Nov 2015

Chemotherapy News and Research

Latest Chemotherapy News and Research

Personalized approach to treating side-effects of chemotherapy better for cancer patients

Loyola and Notre Dame researchers report promising new approaches to treating cancer

New research examines previously unknown secret to DNA repair

MD Anderson study reveals why chemotherapy drugs not effective for many pancreatic cancer patients

Surgical lung resection can improve outcomes in high-risk patients with early stage disease

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Researchers find greater genetic diversity among cancer cells than anticipated

Cancer survivors' journeys chronicled by Bethlehem artist and cancer survivor Susan Schaffer

Agios announces data from dose-escalation phase 1 study of AG-120 in patients with IDH1 mutant positive advanced solid tumors

NTU Singapore scientists harness dead bacteria to destroy colon tumours cells effectively

Novel genetic therapy treats ‘incurable’ leukaemia

Communication network makes astrocytomas more resistant to treatment

Higher insulin levels linked to worse prognosis in advanced breast cancer

Researchers team up to evaluate biological and genetic differences of GI cancers in race, ethnicity

Drugs that target malignant cells increase life expectancy in advanced breast cancer patients

CK5 protein marks ovarian cancer likely to be resistant to cisplatin

CA 19-9 tumor marker test can help predict early-stage pancreatic cancer patients

Study explores benefits of breast cancer adjuvant therapies

New clinical trial uses aggressive treatment method for patients with pancreas cancer

Chemotherapy treatment can contribute to long-term neurocognitive deficits in pediatric brain tumor survivors

Cancer Research - Second Edition eBook

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Newsletters you may be interested in